– Enbumyst™ Is the First and Only FDA-Approved Nasal Spray Loop Diuretic for Edema Associated with Congestive Heart Failure, Expected to Leverage Esperion's Established Cardiovascular Commercial Infrastructure, Synergistically Expand Product Portfolio and Accelerate Double-Digit Revenue Growth – The transaction is expected to close in the second quarter of 2026. "This acquisition represents a compelling and strategically aligned opportunity that accelerates Esperion's momentum and advances our long-term Vis ...